Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$47.2 - $67.81 $17.7 Million - $25.4 Million
-374,435 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$30.93 - $59.48 $9.82 Million - $18.9 Million
-317,380 Reduced 45.88%
374,435 $20.8 Million
Q4 2020

Feb 16, 2021

SELL
$18.53 - $31.5 $3.86 Million - $6.55 Million
-208,042 Reduced 23.12%
691,815 $21.4 Million
Q3 2020

Nov 16, 2020

BUY
$14.68 - $19.12 $13.2 Million - $17.2 Million
899,857 New
899,857 $16.7 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.